Men with prostate cancer could soon join life-saving clinical trials within hours thanks to Prostate Progress – a groundbreaking platform developed by Prostate Cancer Research and backed by the NHS. 

For the first time, patient-reported outcomes such as symptoms, side effects, and quality of life will be securely linked to NHS clinical records in real time. This means men can be matched to relevant clinical trials in hours rather than weeks, speeding up access to treatments and improving survival rates. 

The platform also creates a powerful, anonymous research resource, helping scientists personalise medicine, track side effects, reduce inequalities in care, and shape future targeted screening programmes. The next phase will link data to bio-banked tissue samples and AI tools, unlocking even more potential for tailored treatments. 

So far, 4,000 men have joined the pilot in the North West, West Midlands, and London, with plans to expand to 40,000 participants over the next year – making it the largest platform of its kind in the UK. 9 out of 11 NHS regions are already on board. 

Health Secretary Wes Streeting, himself a cancer survivor, called the scheme part of a “medical revolution,” saying: “Every minute matters once the cancer clock starts ticking.” 

Oliver Kemp, CEO of Prostate Cancer Research, said: “Together, we can stop needless delays and give every man the best chance of a longer, healthier life.” 

Find out more - https://www.prostate-cancer-research.org.uk/prostate-progress/ 

Read the full article by The Telegraph - https://www.telegraph.co.uk/news/2025/08/06/prostate-cancer-patients-to-be-fast-tracked-drug-trials/